Cleared Traditional

K131392 - ETIAM PACS COMPONENTS

K131392 is an FDA 510(k) clearance for ETIAM PACS COMPONENTS, manufactured by Etiam S.A.S.U.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K131392 · Etiam S.A.S.U. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
15d
Days
Class 2
Risk

K131392 is an FDA 510(k) clearance for the ETIAM PACS COMPONENTS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Etiam S.A.S.U. (Rennes, FR). The FDA issued a Cleared decision on May 29, 2013 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K131392

510(k) Number K131392 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 14, 2013
Decision Date May 29, 2013
Days to Decision 15 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 107d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2240
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K131392.
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K130542 · Fujifilm Medical System U.S.A., Inc. · Jun 2013
MR PERMEABILITY
K130278 · Philips Medical Systems Nederland B.V. · May 2013
NIO COLOR 3MP LED
K131295 · Barco N.V. · May 2013
CORONIS 3MP
K131246 · Barco N.V. · May 2013
ANYTHINK PACS WORKSTATION
K131299 · Beijing Crealife Technology Co., Ltd. · May 2013
NORDIC TUMOREX
K123306 · Nordicneurolab · May 2013